A multinational survey investigating the unmet needs and patient perspectives concerning Proton Pump Inhibitors in Systemic Sclerosis.

Despite the frequent use of PPIs in SSc, there is significant heterogeneity in use, and combination therapy (PPIs plus other medication for acid reflux) is not uncommon (~40%). Patients have significant concerns about PPIs side effects. Education about PPIs is often neglected, and patients very frequently use online sources to obtain information on drug treatment. A surgical approach is infrequently discussed, and patients fear this potential therapeutic approach. This article is protected by copyright. All rights reserved.